Benfotiamine EU Novel Food Status — EFSA Opinion October 2026

Do not let one positive answer fill the empty fields.

Record scientific safety, bioavailability, nutrient-source assessment, legal authorisation, label conversion and country requirements independently. For this dossier, unresolved characterisation, particle, process, microbiological stability, metabolism and toxicology questions mattered. Neither a familiar vitamin name nor a proposed intake resolves those gaps.

In Suppvera, formal EU and nutrient-source authorisation remain not established here, rather than automatically “not authorised”. A current legal-status check must follow its own sources; this article does not claim that search has been completed.

Ask for a material-specific evidence map.

1. Identify the exact supplier material, manufacturing method and specification version; do not match only by ingredient name.
2. Map available identity, particle, stability and toxicology documents to the gaps in the opinion; document what remains missing.
3. Obtain the separate legal basis for the exact Novel Food and nutrient source, and assess the intended country and population.
4. Do not calculate label thiamin or an authorised dose from a proposed intake or an unestablished conversion factor.

Use the checklist to organise a review with your supplier or regulatory adviser. It does not send a request, authenticate a document, validate a study or predict the outcome of a new application.

A useful internal handoff identifies the exact specification version, which question each document addresses, who owns the missing information and which intended use is being assessed. Keep assumptions visible instead of turning document receipt into a green result.